Fact CheckerSign in

NCT06585943Recruiting

I-Score: Intensive Stroke Cycling for Optimal Recovery and Economic Value

The I-Score (Intensive Stroke Cycling for Optimal Recovery and Economic Value) Trial

Source: ClinicalTrials.gov · Last updated 16 Sept 2026

Brief summary (registry, in English)

Traditional rehabilitation approaches are time and personnel intensive and costly, and leave \~75% of stroke survivors with residual disability. We propose a clinical trial to determine effects of forced aerobic exercise (FE; i.e., mechanically supplemented) in facilitating upper and lower extremity motor recovery post-stroke in an outpatient rehabilitation setting, to elucidate neural and biochemical substrates of FE-induced motor recovery, and to evaluate cost effectiveness of a FE-centered intervention compared to traditional stroke rehabilitation. The global effect of FE has the potential to enhance recovery in a growing population of stroke survivors in a cost-effective manner, thus accelerating its clinical acceptance.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
66 (estimated)
First submitted
27 Aug 2024
Start date
18 Sept 2024
Primary completion date
Oct 2028
Lead sponsor
The Cleveland Clinic
Diseases
Stroke
NCT number
NCT06585943

What you commit to

  • Study type: Interventional
  • Planned participants: 66
  • From 18 Sept 2024 to the primary completion date, Oct 2028
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • actively undergoing physical or occupational therapy or enrolled in another interventional study
  • skull hardware (e.g. screws/plates) or prior craniotomies that could shunt current flow altering EEG measures

Other illness

  • hospitalization for myocardial infarction, heart failure or heart surgery within 3 months
  • cardiac arrhythmia
  • history of multiple strokes
  • untreated deep vein thrombosis or pulmonary embolus
  • unstable angina
  • uncontrolled hypertension
  • clinically significant neurologic condition/diagnosis other than stroke
  • recent history of elicit drug or alcohol misuse or significant mental health illness

Other

  • hypertrophic cardiomyopathy
  • severe aortic stenosis
  • implanted pacemaker or defibrillator
  • dyspnea at rest
  • significant contractures
  • anti-spasticity injection within 3 months of enrollment
  • other contraindication to exercise or EEGs

Criteria the registry did not label

  • Sixty-six individuals with chronic stroke able to provide informed consent who meet the following criteria for inclusion will be recruited from the Cleveland Clinic:
  • 3-9 months following single ischemic or hemorrhagic stroke confirmed with neuroimaging (ie: first-time stroke)
  • Fugl-Meyer motor score 19-55 in the involved UE
  • Fugl-Meyer score \<34 in the involved LE demonstrating residual hemiparesis
  • Ambulatory ≥ 20 meters with no more than contact guard assistance
  • 18-85 years of age

Age in the registry: 18 years to 85 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Cleveland Clinic
Coordinator of this site? Confirm its status
ClevelandUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.